Sažetak sa skupa
https://doi.org/10.26800/LV-142-supp5-35
Rome IV Diagnostic Criteria for Irritable Bowel Syndrome in polycystic ovary syndrome patients
Małgorzata Kałużnata
; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poland
Pola Kompf
; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poland
Magdalena Człapka-Matyasik
; Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences, Poland
Katarzyna Wachowiak-Ochmańska
; Heliodor Święcicki Clinical Hospital, Poznan, Poland
Jerzy Moczko
; Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poland
Katarzyna Ziemnicka
; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poland
Marek Ruchała
; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poland
Sažetak
Introduction:
Polycystic ovary syndrome (PCOS) is a complex endocrinopathy affecting 4-21% of women worldwide. PCOS patients may present with gastrointestinal (GI) disturbances more often than healthy women. Irritable Bowel Syndrome (IBS) is a functional GI system disorder affecting 10-20% of the general population. Research shows that young females are most severely affected by IBS. Links between these conditions have received limited attention in research thus far.
Ključne riječi
Irritable Bowel Syndrome (IBS); Rome IV (Diagnostic) Criteria; polycystic ovary syndrome (PCOS)
Hrčak ID:
257249
URI
Datum izdavanja:
27.1.2021.
Posjeta: 759 *